Literature DB >> 33664522

Maintaining 'standards' for biosimilar monoclonal antibodies.

Sandra Prior1, Clive Metcalfe2, Simon E Hufton2, Meenu Wadhwa2, Christian K Schneider2,3, Chris Burns2.   

Abstract

Mesh：

Substances：

Year:  2021        PMID： 33664522     DOI： 10.1038/s41587-021-00848-0

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab.

Authors:  Haiyan Jia; Parvathy Harikumar; Eleanor Atkinson; Peter Rigsby; Meenu Wadhwa
Journal:  Biomolecules       Date:  2021-10-30

2.  WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, virtual meeting, 30 June - 2 July 2021.

Authors:  Meenu Wadhwa; Hye-Na Kang; Robin Thorpe; Ivana Knezevic; P Aprea; M-C Bielsky; N Ekman; H-K Heim; J Joung; P Kurki; E Lacana; C Njue; E Nkansah; M Savkina; R Thorpe; T Yamaguchi; M Wadhwa; J Wang; M Weise; E Wolff-Holz
Journal:  Biologicals       Date:  2022-04-22       Impact factor: 1.760

Review 3.  Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19.

Authors:  Serena Patel; Meenu Wadhwa
Journal:  Biomed Pharmacother       Date:  2021-05-28       Impact factor: 6.529

4.  New Quality-Range-Setting Method Based on Between- and Within-Batch Variability for Biosimilarity Assessment.

Authors:  Alexis Oliva; Matías Llabrés
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.